Cargando…

Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method

BACKGROUND: Studies disagree on the location of grey matter (GM) atrophy in the multiple sclerosis (MS) brain. AIM: To examine the consistency between FSL, FreeSurfer, SPM for GM atrophy measurement (for volumes, patient/control discrimination, and correlations with cognition). MATERIALS AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Popescu, Veronica, Schoonheim, Menno M., Versteeg, Adriaan, Chaturvedi, Nimisha, Jonker, Marianne, Xavier de Menezes, Renee, Gallindo Garre, Francisca, Uitdehaag, Bernard M. J., Barkhof, Frederik, Vrenken, Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706325/
https://www.ncbi.nlm.nih.gov/pubmed/26745873
http://dx.doi.org/10.1371/journal.pone.0143942
_version_ 1782409147881357312
author Popescu, Veronica
Schoonheim, Menno M.
Versteeg, Adriaan
Chaturvedi, Nimisha
Jonker, Marianne
Xavier de Menezes, Renee
Gallindo Garre, Francisca
Uitdehaag, Bernard M. J.
Barkhof, Frederik
Vrenken, Hugo
author_facet Popescu, Veronica
Schoonheim, Menno M.
Versteeg, Adriaan
Chaturvedi, Nimisha
Jonker, Marianne
Xavier de Menezes, Renee
Gallindo Garre, Francisca
Uitdehaag, Bernard M. J.
Barkhof, Frederik
Vrenken, Hugo
author_sort Popescu, Veronica
collection PubMed
description BACKGROUND: Studies disagree on the location of grey matter (GM) atrophy in the multiple sclerosis (MS) brain. AIM: To examine the consistency between FSL, FreeSurfer, SPM for GM atrophy measurement (for volumes, patient/control discrimination, and correlations with cognition). MATERIALS AND METHODS: 127 MS patients and 50 controls were included and cortical and deep grey matter (DGM) volumetrics were performed. Consistency of volumes was assessed with Intraclass Correlation Coefficient/ICC. Consistency of patients/controls discrimination was assessed with Cohen’s d, t-tests, MANOVA and a penalized double-loop logistic classifier. Consistency of association with cognition was assessed with Pearson correlation coefficient and ANOVA. Voxel-based morphometry (SPM-VBM and FSL-VBM) and vertex-wise FreeSurfer were used for group-level comparisons. RESULTS: The highest volumetry ICC were between SPM and FreeSurfer for cortical regions, and the lowest between SPM and FreeSurfer for DGM. The caudate nucleus and temporal lobes had high consistency between all software, while amygdala had lowest volumetric consistency. Consistency of patients/controls discrimination was largest in the DGM for all software, especially for thalamus and pallidum. The penalized double-loop logistic classifier most often selected the thalamus, pallidum and amygdala for all software. FSL yielded the largest number of significant correlations. DGM yielded stronger correlations with cognition than cortical volumes. Bilateral putamen and left insula volumes correlated with cognition using all methods. CONCLUSION: GM volumes from FreeSurfer, FSL and SPM are different, especially for cortical regions. While group-level separation between MS and controls is comparable, correlations between regional GM volumes and clinical/cognitive variables in MS should be cautiously interpreted.
format Online
Article
Text
id pubmed-4706325
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47063252016-01-15 Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method Popescu, Veronica Schoonheim, Menno M. Versteeg, Adriaan Chaturvedi, Nimisha Jonker, Marianne Xavier de Menezes, Renee Gallindo Garre, Francisca Uitdehaag, Bernard M. J. Barkhof, Frederik Vrenken, Hugo PLoS One Research Article BACKGROUND: Studies disagree on the location of grey matter (GM) atrophy in the multiple sclerosis (MS) brain. AIM: To examine the consistency between FSL, FreeSurfer, SPM for GM atrophy measurement (for volumes, patient/control discrimination, and correlations with cognition). MATERIALS AND METHODS: 127 MS patients and 50 controls were included and cortical and deep grey matter (DGM) volumetrics were performed. Consistency of volumes was assessed with Intraclass Correlation Coefficient/ICC. Consistency of patients/controls discrimination was assessed with Cohen’s d, t-tests, MANOVA and a penalized double-loop logistic classifier. Consistency of association with cognition was assessed with Pearson correlation coefficient and ANOVA. Voxel-based morphometry (SPM-VBM and FSL-VBM) and vertex-wise FreeSurfer were used for group-level comparisons. RESULTS: The highest volumetry ICC were between SPM and FreeSurfer for cortical regions, and the lowest between SPM and FreeSurfer for DGM. The caudate nucleus and temporal lobes had high consistency between all software, while amygdala had lowest volumetric consistency. Consistency of patients/controls discrimination was largest in the DGM for all software, especially for thalamus and pallidum. The penalized double-loop logistic classifier most often selected the thalamus, pallidum and amygdala for all software. FSL yielded the largest number of significant correlations. DGM yielded stronger correlations with cognition than cortical volumes. Bilateral putamen and left insula volumes correlated with cognition using all methods. CONCLUSION: GM volumes from FreeSurfer, FSL and SPM are different, especially for cortical regions. While group-level separation between MS and controls is comparable, correlations between regional GM volumes and clinical/cognitive variables in MS should be cautiously interpreted. Public Library of Science 2016-01-08 /pmc/articles/PMC4706325/ /pubmed/26745873 http://dx.doi.org/10.1371/journal.pone.0143942 Text en © 2016 Popescu et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Popescu, Veronica
Schoonheim, Menno M.
Versteeg, Adriaan
Chaturvedi, Nimisha
Jonker, Marianne
Xavier de Menezes, Renee
Gallindo Garre, Francisca
Uitdehaag, Bernard M. J.
Barkhof, Frederik
Vrenken, Hugo
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method
title Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method
title_full Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method
title_fullStr Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method
title_full_unstemmed Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method
title_short Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method
title_sort grey matter atrophy in multiple sclerosis: clinical interpretation depends on choice of analysis method
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706325/
https://www.ncbi.nlm.nih.gov/pubmed/26745873
http://dx.doi.org/10.1371/journal.pone.0143942
work_keys_str_mv AT popescuveronica greymatteratrophyinmultiplesclerosisclinicalinterpretationdependsonchoiceofanalysismethod
AT schoonheimmennom greymatteratrophyinmultiplesclerosisclinicalinterpretationdependsonchoiceofanalysismethod
AT versteegadriaan greymatteratrophyinmultiplesclerosisclinicalinterpretationdependsonchoiceofanalysismethod
AT chaturvedinimisha greymatteratrophyinmultiplesclerosisclinicalinterpretationdependsonchoiceofanalysismethod
AT jonkermarianne greymatteratrophyinmultiplesclerosisclinicalinterpretationdependsonchoiceofanalysismethod
AT xavierdemenezesrenee greymatteratrophyinmultiplesclerosisclinicalinterpretationdependsonchoiceofanalysismethod
AT gallindogarrefrancisca greymatteratrophyinmultiplesclerosisclinicalinterpretationdependsonchoiceofanalysismethod
AT uitdehaagbernardmj greymatteratrophyinmultiplesclerosisclinicalinterpretationdependsonchoiceofanalysismethod
AT barkhoffrederik greymatteratrophyinmultiplesclerosisclinicalinterpretationdependsonchoiceofanalysismethod
AT vrenkenhugo greymatteratrophyinmultiplesclerosisclinicalinterpretationdependsonchoiceofanalysismethod